Ultragenyx Pharmaceutical | RARE - Ebitda





Ebitda Veränderung Datum
Acadia Pharmaceuticals USD 20.31M 15.44M 2025-12
Agios Pharmaceuticals USD -120.31M 4.82M 2025-12
Alnylam Pharmaceuticals USD 145.22M 236.56M 2025-12
BioCryst Pharmaceuticals USD 51.7M 30.14M 2025-09
BioMarin Pharmaceutical USD 146.05M 170.22M 2026-03
Immunic USD -22.78M 753K 2024-06
Insmed USD -148.3M 165.88M 2026-03
Ionis Pharmaceuticals USD -200.02M 42.89M 2025-12
Karyopharm Therapeutics USD -26.2M 1.83M 2024-09
Kyowa Hakko Kirin JPY 17.17B 28.58B 2026-03
MacroGenics USD -30.2M 52.15M 2026-03
Moderna USD -790M 582M 2025-12
Neurocrine Biosciences USD 193.3M 25.1M 2026-03
PTC Therapeutics USD -70.99M 91.62M 2025-12
Puma Biotechnology USD 729K 11.36M 2024-06
Regeneron Pharmaceuticals USD 1.2B 718.4M 2025-12
Sarepta Therapeutics USD -252.2M 84.16M 2025-12
Ultragenyx Pharmaceutical USD -99.43M 57.35M 2025-12
Vertex Pharmaceuticals USD 1.19B 195.3M 2026-03